Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference newsletter

  Ovarian Neoplasms

  Free Subscription


1 Cancer
3 Clin Cancer Res
3 Gynecol Oncol
1 J Natl Cancer Inst
1 Oncology

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. GHIRARDI V, Ronsini C, Trozzi R, Di Ilio C, et al
    Hyperthermic intraperitoneal chemotherapy in interval debulking surgery for advanced epithelial ovarian cancer: A single-center, real-life experience.
    Cancer. 2020 Sep 15. doi: 10.1002/cncr.33167.
    PubMed         Abstract available

    Clin Cancer Res

  2. YANG H, Mao W, Rodriguez-Aguayo C, Mangala LS, et al
    Correction: Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability.
    Clin Cancer Res. 2020;26:5050.

  3. JIN ZH, Tsuji AB, Degardin M, Sugyo A, et al
    Radiotheranostic Agent (64)Cu-cyclam-RAFT-c(-RGDfK-)4 for Management of Peritoneal Metastasis in Ovarian Cancer.
    Clin Cancer Res. 2020 Sep 15. pii: 1078-0432.CCR-20-1205.
    PubMed         Abstract available

  4. JORDAN K, Sikora MJ, Slansky JE, Minic A, et al
    The capacity of the ovarian cancer tumor microenvironment to integrate inflammation signaling conveys a shorter disease-free interval.
    Clin Cancer Res. 2020 Sep 14. pii: 1078-0432.CCR-20-1762.
    PubMed         Abstract available

    Gynecol Oncol

  5. HURWITZ LM, Pinsky PF, Huang WY, Freedman ND, et al
    Aspirin use and ovarian cancer risk using extended follow-up of the PLCO Cancer Screening Trial.
    Gynecol Oncol. 2020 Sep 10. pii: S0090-8258(20)33855.
    PubMed         Abstract available

  6. PLETT H, Filippova OT, Garbi A, Kommoss S, et al
    Role of delayed interval debulking for persistent residual disease after more than 5 cycles of chemotherapy for primary advanced ovarian cancer. An international multicenter study.
    Gynecol Oncol. 2020 Sep 9. pii: S0090-8258(20)33829.
    PubMed         Abstract available

  7. MADARIAGA A, Garg S, Bruce JP, Thiryayi S, et al
    Biomarkers of outcome to weekly paclitaxel in epithelial ovarian cancer.
    Gynecol Oncol. 2020 Sep 7. pii: S0090-8258(20)33849.
    PubMed         Abstract available

    J Natl Cancer Inst

  8. VOS JR, Ligtenberg MJL, Hoogerbrugge N
    Response to Tomao, Panici, and Tomao.
    J Natl Cancer Inst. 2020;112:425.


  9. STEFFEN T, Haller L, Bijelic L, Glatzer M, et al
    Decision-Making Analysis for Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer: A Survey by the Executive Committee of the Peritoneal Surface Oncology Group International (PSOGI).
    Oncology. 2020 Sep 11:1-8. doi: 10.1159/000510098.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.